85-1792-83　Elacridar hydrochloride (GF 120918, P-gp inhibitor, (N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-­2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-m­ethoxy-9-oxo-4-acridinecarboxamide hydrochloride) 10mg　CAS No:143851-98-3　145672

特徴

• P-glycoprotein (P-gp/ABCG1) inhibitor. Blocks P-gp-mediated multidrug resistance (MDR) of the cytotoxic drugs doxorubicin and vincristine in CHRC5 cells. Also inhibits breast cancer resistance protein (BCRP/ABCG2). Orally active.
• Sequence:C34H33N3O5.HCl
• Solubility:DMSO (~50mM)
• Molecular Weight:~600.1
• Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：10mg
• Grade：Highly Purified
• Purity：~98% (HPLC)
• Form：Supplied as a yellow solid.
• Molecular Formula：C34H33N3O5.HCl
• Molecular Weight Non Ab：600.1
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
• CAS No ：143851-98-3

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]